Use and description |
Compound 7p was developed as one in series of compounds with the aim of identifying dual-acting thromboxane receptor antagonist/synthase inhibitors . In fact compound 7p shows selectivity for prostaglandin I2 synthase (PTGIS , CYP8A1) over thromboxane synthase (CYP5A1).Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential , and one of the strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways. |
Physical Characters and Index |
Product Name:Compound 7P CAS:1890208-58-8 Molecular Formula:C22H23N3O5S Molecular Weight:441.5 Appearance:White powder. Density:1.329±0.06 g/cm3(Predicted) |